Can Diazepam Help with Akathisia?
Yes, diazepam can be used to treat akathisia and is supported by current clinical guidelines as one of several effective treatment options.
Guideline-Based Recommendations
The most recent international guidelines explicitly support benzodiazepines for akathisia management. The 2020 APA Practice Guideline recommends that for patients with akathisia associated with antipsychotic therapy, clinicians should consider: lowering the antipsychotic dosage, switching to another antipsychotic, adding a benzodiazepine medication, or adding a beta-adrenergic blocking agent 1. This represents a Level 2C recommendation, indicating moderate clinical support.
The 2025 INTEGRATE guidelines from The Lancet Psychiatry similarly acknowledge that akathisia can be managed with dose reduction, switching to quetiapine or olanzapine, or alternatively using adjunctive propranolol 2.
Evidence Quality and Ranking
Benzodiazepines rank as the most effective pharmacological intervention for akathisia based on the most recent network meta-analysis. A 2024 comprehensive review analyzing 13 controlled trials with 446 patients found that benzodiazepines achieved the highest P-score (0.8186) for efficacy, outperforming beta-blockers and NaSSA (noradrenergic and specific serotonergic antidepressants) 3. This represents the strongest comparative evidence available.
Clinical Evidence for Diazepam Specifically
A 2002 open-label study demonstrated that intravenous diazepam provides immediate relief from severely distressing akathisia. All 18 patients with schizophrenia or bipolar disorder who developed neuroleptic-induced acute akathisia experienced immediate symptom relief after IV diazepam administration (mean dose 12.6 mg, range 10-17 mg) with no serious adverse effects 4. This supports diazepam's use when rapid symptom control is needed.
Treatment Algorithm
For acute, distressing akathisia:
- First-line: Add diazepam (typically 5-10 mg orally, or IV for severe cases requiring immediate relief)
- Alternative first-line: Propranolol 10-30 mg two to three times daily 2
- Concurrent consideration: Reduce antipsychotic dose if clinically feasible
- If refractory: Switch to quetiapine or olanzapine 2
For chronic or treatment-resistant akathisia:
- Consider mirtazapine 15 mg, which showed efficacy in a 2024 case report where benzodiazepines and anticholinergics failed 5
- Note that anticholinergics are NOT effective for akathisia (unlike acute dystonia) 1
Important Caveats
Benzodiazepine risks must be weighed carefully. The FDA label for diazepam emphasizes risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions 6. These risks are particularly relevant in psychiatric populations. Use the lowest effective dose and avoid long-term continuous use when possible.
Akathisia can be misdiagnosed as anxiety disorders, particularly in pregnancy or other vulnerable populations 7. The key distinguishing feature is the motor component—patients cannot sit still and have an overwhelming urge to move, not just subjective anxiety.
One case series noted akathisia unresponsive to diazepam in three schizophrenic patients, though this appears to be the exception rather than the rule 8. If standard treatments fail, consider alternative diagnoses or contributing factors (such as synthetic cathinone use, which can cause treatment-resistant akathisia 9).
Practical Implementation
Diazepam can be administered orally for routine management or intravenously when immediate relief is required for severe distress 4. The typical oral dose range is 5-10 mg, adjustable based on response. Monitor for sedation and counsel patients about CNS depressant effects and the importance of avoiding alcohol 6.
Given the comparative efficacy data showing benzodiazepines as the top-ranked intervention 3 and guideline support 1, diazepam represents a legitimate, evidence-based option for akathisia management, particularly when beta-blockers are contraindicated or when rapid symptom control is needed.